Drawing for PLEOTHERAPY

USPTO serial 79225505

PLEOTHERAPY

Reviewed by CopyMark Law Group

Reg. 5705799Status 709
Filing date
Status date
Registration date
Mar 26, 2019
Examiner
JAGANNATHAN, SIDDHARTH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PLEOTHERAPY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeff D. Larson

JEFF D. LARSON HOLLAND & HART LLPATTENTION TRADEMARK DOCKETINGP.O. BOX 8749DENVER, CO 80201

Goods and services

ClassDescriptionStatusFirst use
035Compilation and management of databases and central data files in the field of pharmaceutical research and development, scientific research regarding medicine, medicine and clinical trials; compilation of statistics for business or commercial purposes; collection and systematization of data in a central file; public relations; communication, namely, promoting public awareness of programs concerning the treatment of diseasesSECTION 71 - CANCELLED—
041Training services in the pharmaceutical field; publication of books and texts other than advertising texts; electronic publication of texts in the field of pharmaceutical research and development, scientific research regarding medicine, online medicine; organization and conducting of colloquiums, conferences, congresses, seminars in the pharmaceutical and medical field; teaching in the pharmaceutical fieldSECTION 71 - CANCELLED—
042Pharmaceutical research and development; scientific research regarding medicine; conducting of clinical trials and studies; chemical and biological analysis for scientific research purposes; scientific research in chemistry, cosmetology, biology, bacteriology, nutrition and biotechnology; biological research for the diagnosis, prevention and treatment of neurodegenerative, metabolic, inflammatory, cancerous and cardiac diseases, diabetes and obesity and any other diseases; biological research services in the field of chemical, biological and pharmaceutical products; software design and development; scientific laboratory services; scientific research on chemical reagents for medical use, namely, biomarkersSECTION 71 - CANCELLED—
044Providing medical information, namely, pharmaceutical advice using information gathered from pharmaceutical research and clinical trialsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 10, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 10, 2025C71TCANCELLED SECTION 71—
Mar 26, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 21, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 16, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 26, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 26, 2019FIMPFINAL DISPOSITION PROCESSED—
Jun 26, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 26, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 8, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 8, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 19, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 30, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 29, 2018ALIEASSIGNED TO LIE—
Nov 13, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 9, 2018GPNXNOTIFICATION PROCESSED BY IB—
Nov 8, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 8, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Nov 8, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 8, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 8, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 31, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 26, 2018PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Oct 24, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 24, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 24, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 17, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 17, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 15, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 14, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 14, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 30, 2018RFNPREFUSAL PROCESSED BY IB—
Mar 15, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 15, 2018RFRRREFUSAL PROCESSED BY MPU—
Mar 7, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 6, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2018RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Feb 20, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 19, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2018DOCKASSIGNED TO EXAMINER—
Feb 2, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 29, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 25, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance